Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liprostin with Angioplasty in PAOD
NCT00053716Phase 2Unknown
- Sponsor
- Endovasc
- Start
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Liprostin in peripheral arterial occlusive disease (PAOD), sponsored by Endovasc. Status: unknown.
02
Drugs
Liprostin
03
Conditions
peripheral arterial occlusive disease (PAOD)
Beyond the preview
Go deeper on NCT00053716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00053716.